Maher TM, et al. - For this investigation, interviews and/or online surveys were completed by patients and pulmonologists from Canada, France, Germany, Italy, Spain, and the UK to examine the views of people with idiopathic pulmonary fibrosis (IPF) and pulmonologists on the diagnosis and management of IPF to understand treatment patterns. Researchers reported that differences between countries were observed regarding physicians’ comfort in addressing the prognosis at diagnosis and access to care. They identified several barriers to antifibrotic treatment, principally reflecting the differing views and values of patients and physicians, implying a need for better patient-physician communication about pharmacological therapy for IPF.